Guang-Liang Chen

6PUBLICATIONS
10CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursMedical and biological physics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 22, 2026
Durable Intracranial Response to Sacituzumab Tirumotecan in HER2-Negative Salivary Duct Carcinoma With High TROP2 Expression: A Case Report.

|Aug 11, 2026
Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.

|Oct 30, 2024
PD-1 inhibitors plus chemotherapy for refractory EBV-positive DLBCL: a retrospective analysis.

Youli Li, Yonghe Wu, Sufen Cao

|Aug 29, 2024
Chidamide plus R-GDP for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for autologous transplantation: A prospective, single-arm, phase II study.

Guang-Liang Chen, Kai Xue, Qunling Zhang

|Sep 09, 2021
Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.

Zhen Lin, Yi-Zhao Xie, Ming-Chun Zhao

|Feb 10, 2021
Characterization of Artificial Pneumothorax-Unrelated Pyothorax-Associated Lymphoma.

Guang-Liang Chen, Zu-Guang Xia, Jia Jin

Pageof 1

Frequent Collaborators

2 joint publications

Xin Liu

2 joint publications

Dongmei Ji

1 joint publications

Junning Cao

1 joint publications

Zu-Guang Xia